Highlights
  • Higher-than-expected Non-Farm Payrolls, strong U.S. dollar and resilient U.S. economy have pressured gold price throughout January to end the month at $2,067.40/oz. (-0.2% MoM). Ongoing conflicts in the red sea and expectations of rate cuts later in 2024 have provided support to the shiny metal, even if the expectations of the timing and quantity of those cuts continue to fluctuate with data. The opposing factors in play are pulling down the managed money net position as market participants looking for more signs of direction.
  • Without its yellow counterpart leading the way, silver prices remained weak and closed the month down 3.8% at $23.170/oz. Managed money net position has turned negative for the first time in four months.
  • The recent announcement of the Chinese government to cut banks’ Required Reserve Ratio by 0.5% and the tight copper supply situation have pushed the prices up by 0.4% to settle the month at $3.9060/lb. The doubt over Chinese demand recovery in the new year and contracting Chinese manufacturing activity continues to put a cap on the upside.
  • Micro Gold futures (MGC) QTD average daily volume (ADV) and average daily open interest (ADOI) of 67,390 contracts and 35,977 contracts are up 6% and 12%, respectively, compared to Q4 2023. In the same period, Micro Copper futures (MHG) QTD ADV of 4,432 contracts is up 14% while ADOI of 3,126 contracts achieved historical high since launch. Market participants can tap on the liquidity growth to hedge or take positions effectively.

Micro Gold (MGC), Micro Silver (SIL) and Micro Copper (MHG) Futures Update

MGC, SIL and MHG price movement and daily range (expressed in terms of one lot notional)

*Intraday price movement is expressed as the difference between the daily high price and the daily low price multiplied by the contract notional in troy ounce (MGC and SIL) and pounds (MHG).

Options Heatmap (Change in OI from January 2 to January 31, 2024)

Key Economic Events in February/March 2024:

Key Economic Event

ET

GMT / BST

SGT / HKT

U.S. ISM Manufacturing PMI

Feb 1, 10.00 a.m.

Feb 1, 3.00 p.m.

Feb 1, 11.00 p.m.

U.S. Non Farm Payrolls

Feb 2, 8.30 a.m.

Feb 2, 1.30 p.m.

Feb 2, 9.30 p.m.

China Inflation Rate YoY

Feb 7, 8.30 p.m.

Feb 8, 1.30 a.m.

Feb 8, 9.30 a.m.

U.S. Inflation Numbers

Feb 13, 8.30 a.m.

Feb 13, 1.30 p.m.

Feb 13, 9.30 p.m.

FOMC Minutes

Feb 21, 2.00 p.m.

Feb 21, 7.00 p.m.

Feb 22, 3.00 a.m.

U.S. Core PCE Price Index

Feb 29, 8.30 a.m.

Feb 29, 1.30 p.m.

Feb 29, 9.30 p.m.

China NBS Manufacturing PMI

Feb 29, 8.30 p.m.

Mar 1, 1.30 a.m.

Mar 1, 9.30 a.m.

China Caixin Manufacturing PMI

Feb 29, 8.45 p.m.

Mar 1, 1.45 a.m.

Mar 1, 9.45 a.m.

U.S. ISM Manufacturing PMI

Mar 1, 10.00 a.m.

Mar 1, 3.00 p.m.

Mar 1, 11.00 p.m.

China Balance of Trade

Mar 6, 11.30 p.m.

Mar 7, 4.30 a.m.

Mar 7, 12.30 p.m.

U.S. Non Farm Payrolls

Mar 8, 8.30 a.m.

Mar 8, 1.30 p.m.

Mar 8, 9.30 p.m.

China Inflation Rate YoY

Mar 8, 8.30 p.m.

Mar 9, 1.30 a.m.

Mar 9, 9.30 a.m.

U.S. Inflation Numbers

Mar 12, 8.30 a.m.

Mar 12, 12.30 p.m.

Mar 12, 8.30 p.m.

China Industrial Production YoY

Mar 17, 10.00 p.m.

Mar 18, 2.00 a.m.

Mar 18, 10.00 a.m.

U.S. Fed Interest Rate Decision and Fed Press Conference

Mar 20, 2.00 p.m.

Mar 20, 6.00 p.m.

Mar 21, 2.00 a.m.

U.S. Core PCE Price Index

Mar 29, 8.30 a.m.

Mar 29, 12.30 p.m.

Mar 29, 8.30 p.m.

China NBS Manufacturing PMI

Mar 30, 9.30 p.m.

Mar 31, 1.30 a.m.

Mar 31, 9.30 a.m.

China Caixin Manufacturing PMI

Mar 31, 9.45 p.m.

Apr 1, 1.45 a.m.

Apr 1, 9.45 a.m.

Source: CME Group, Quikstrike

Useful resources

Stay up-to-date with the latest probabilities of FOMC rate moves with the CME FedWatch Tool.

The Commitments of Traders (COT) tool can provide a comprehensive and highly configurable graphical representation of the CFTC's report on market open interest.

Build and test your trading strategies in a simulated environment with free pricing and analytics tools for CME Group markets. Choose from three ways to access exclusive, web-based tools developed by QuikStrike®.


Disclaimer

Exchange traded derivatives and cleared over-the-counter (“OTC”) derivatives are not suitable for all investors and involve the risk of loss. Exchange traded and OTC derivatives are leveraged instruments and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money initially deposited. This communication does not (within the meaning of any applicable legislation) constitute a Prospectus or a public offering of securities; nor is it a recommendation, offer, invitation or solicitation to buy, sell or retain any specific investment or service.

The content in this communication has been compiled by CME Group for general purposes only and is not intended to provide, and should not be construed as advice. It does not take into account your objectives, financial situation or needs, and you should obtain appropriate professional advice before acting on or relying on the information set out in this communication. Although every attempt has been made to ensure the accuracy of the information within this communication as of the date of publication, CME Group assumes no responsibility for any errors or omissions and will not update it. Additionally, all examples and information in this communication are used for explanation purposes only and should not be considered, investment advice, the results of actual market experience, or the promotion of any particular products or services.  All matters pertaining to rules and specifications herein are made subject to and superseded by official Chicago Mercantile Exchange Inc. (“CME”), the Chicago Board of Trade, Inc. (“CBOT”), the New York Mercantile Exchange, Inc. (“NYMEX”), and the Commodity Exchange, Inc. (“COMEX”) rulebooks or, as applicable, the respective Rulebooks of CME Group’s certain other subsidiary trading facilities. Current rules should be consulted in all cases including matters relevant to contract specifications.

CME Group does not represent that any material or information contained in this communication is appropriate for use or permitted in any jurisdiction or country where such use or distribution would be contrary to any applicable law or regulation. This communication has not been reviewed or approved by any regulatory authority and access shall be at the liability of the user.

In Australia, each of Chicago Mercantile Exchange Inc. (ARBN 103 432 391), Board of Trade of the City of Chicago Inc. (ARBN 110 594 459), New York Mercantile Exchange, Inc. (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence.

In Hong Kong, CME, CBOT, NYMEX and COMEX are authorized by the Hong Kong Securities and Futures Commission (the "SFC") to provide Automated Trading Services ("ATS") via the CME GLOBEX system, and CME is authorized by the SFC to provide ATS via the CME Clearing System, under Part III of the Securities and Futures Ordinance (the "SFO").

In Japan, CME has a Foreign Clearing Organisation (FCO) license under the Financial Instruments and Exchange Act of Japan.

In Singapore, CME, CBOT, NYMEX and COMEX are regulated as a recognized market operator and CME is regulated as a recognized clearing house under the Securities and Futures Act (Chapter 289) ("SFA"). Save as aforesaid, none of the CME Group entities are licensed to carry on regulated activities under the SFA or to provide financial advisory services under the Financial Advisers Act (Chapter 110) in Singapore.

None of CME Group entities are registered or licensed to provide, nor does it purport to provide, financial services of any kind in some jurisdictions, including, but not limited to, India, Korea, Malaysia, New Zealand, People’s Republic of China, Philippines, Thailand, and Vietnam and in any jurisdiction where CME Group is not authorized to do business or where such distribution would be contrary to the local laws and regulations.

You are advised to exercise caution in relation to the information contained herein. If you are in any doubt about any of the contents of this communication, you should obtain independent professional advice. 

In Hong Kong, CME Group is not licensed to carry on business in dealing or advising on futures contracts under the SFO. This communication is for distribution in Hong Kong solely to corporations licensed by the SFC under Part V or authorized under Part III of the SFO.

In Japan, this communication is for distribution solely to certain qualified sophisticated investors as set forth in the Commodities Futures Act of Japan (Law No. 239 of 1950, as amended) and the related rules, as appropriate. Other than that, the information contained in this communication is not directed at any person in Japan and is not intended for marketing or soliciting Japanese customers to trade or use any specific CME products or services.

In the Republic of Korea, this communication is for distribution solely to “professional investors” (as defined in Article 9(5) of the Financial Investment Services and Capital Markets Act and related rules) in response to a request from such professional investors or through a licensed investment broker.

In the People’s Republic of China, this communication is provided to the reader only and shall not be copied or redistributed within the People’s Republic of China for any other purpose. No information contained in this communication constitutes or leads to an offer to provide or sell any financial service or product, a recommendation (express or implied) to take any action in respect of any financial product, or any investment advice or market forecast.

This communication is for distribution in Singapore solely to certain institutional investors (such as persons holding a capital markets services licence for trading in futures contracts or exempt from such requirements under the SFA), to accredited investors and to expert investors (each as defined in the SFA).

In Vietnam, Vietnam residents may be subject to certain statutory conditions for trading on offshore platforms such as CME, CBOT, NYMEX and COMEX and not all products on CME, CBOT, NYMEX and COMEX may be permissible for trading by Vietnam residents. Investors in Vietnam are responsible for ensuring that their trades on CME, CBOT, NYMEX and COMEX are compliant with all relevant laws applicable to them.

CME Group, the Globe Logo, CME, Globex, E-Mini, CME Direct, CME DataMine and Chicago Mercantile Exchange are trademarks of Chicago Mercantile Exchange Inc.  CBOT and the Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago, Inc.  NYMEX and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.

BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.

Certain CME Group subsidiaries are authorised and regulated by regulatory authorities. Certain of those subsidiaries are required to retain records of telephone conversations and other electronic communications for a period of 5 to 7 years where required by certain regulation, copies of which are available on request (which may be subject to a fee). For further regulatory information please see www.cmegroup.com.

Copyright © 2024 CME Group Inc. All rights reserved.
Mailing Address: 20 South Wacker Drive, Chicago, Illinois 60606

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2024 CME Group Inc. All rights reserved.